Experts outline changes needed to make the most of Alzheimer’s treatment breakthroughs
A dementia expert at the University of Exeter is part of an international panel to outline thechanges needed to for people to get the greatest benefit from Alzheimer’s treatment breakthrough. The approval of new antibody medications for Alzheimer’s disease – lecanemab and donanemab – and diagnostic tests in the blood mark the beginning of a new era in Alzheimer’s disease diagnosis and treatment. However, Professor Clive Ballard is one of 40 leading Alzheimer’s disease experts to take part…
